Cargando…
Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
Biopsies from 61 sporadic metastatic malignant melanomas and five melanoma cell lines were examined for homozygous deletions and mutations in the CDKN2 gene (p16). As the p16 protein is involved in a cell cycle regulatory pathway consisting of at least pRb, cdk4 and cyclin D1, the tumours were also...
Autores principales: | Maelandsmo, G. M., Flørenes, V. A., Hovig, E., Oyjord, T., Engebraaten, O., Holm, R., Børresen, A. L., Fodstad, O. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075830/ https://www.ncbi.nlm.nih.gov/pubmed/8611425 |
Ejemplares similares
-
The role of p16-cyclin D/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma
por: Tsuda, H, et al.
Publicado: (2000) -
Expression of pRb, p53, p16 and Cyclin D1 and Their Clinical Implications in Urothelial Carcinoma
por: Lee, Kyungji, et al.
Publicado: (2010) -
CDK4, pRB and E2F1: connected to insulin
por: Fajas, Lluis, et al.
Publicado: (2010) -
p16, pRb, and p53 in Feline Oral Squamous Cell Carcinoma
por: Supsavhad, Wachiraphan, et al.
Publicado: (2016) -
Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
por: Maelandsmo, G. M., et al.
Publicado: (1995)